Suchergebnisse - "Younossi, Zobair M"

PubPharm (919)

41

Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States

enthalten in: Metabolism: clinical and experimental | 2023

von Golabi, P. | Paik, J. | Kumar, A. | +5

42

Asia-Pacific association for study of liver guidelines on management of ascites in liver disease

enthalten in: Hepatology international | 2023

von Singh, V. | De, A. | Mehtani, R. | +34

43

The Global Burden of Liver Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2023

von Younossi, Z. | Wong, G. | Anstee, Q. | +1

44

Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)

enthalten in: Annals of hepatology | 2023

von Paik, J. | Eberly, K. | Kabbara, K. | +5

45

Nonalcoholic fatty liver disease mortality may not be decreasing : A need for careful interpretation of GBD 2019 estimates of liver deaths

enthalten in: Cell metabolism | 2023

von Paik, J. | Henry, L. | Younossi, Z.

CommentOn: Cell Metab. 2023 Mar 7;35(3):414-428.e3. - PMID 36889281

46

Healthcare and socioeconomic costs of NAFLD : A global framework to navigate the uncertainties

enthalten in: Journal of hepatology | 2023

von Allen, A. | Lazarus, J. | Younossi, Z.

47

The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Younossi, Z. | Stepanova, M. | Felix, S. | +6

CommentIn: Aliment Pharmacol Ther. 2023 Jun;57(12):1461-1462. - PMID 37243464

48

Reply : NAFLD/MAFLD: One size does not fit all, certainly not for children!

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Henry, L. | Younossi, Z.

CommentOn: Hepatology. 2022 Nov;76(5):1423-1437. - PMID 35363908

49

Asia–Pacific association for study of liver guidelines on management of ascites in liver disease

enthalten in: Hepatology international | 2023

von Singh, V. | De, A. | Mehtani, R. | +32

50

Asia–Pacific association for study of liver guidelines on management of ascites in liver disease

enthalten in: Hepatology international | 2023

von Singh, V. | De, A. | Mehtani, R. | +32